Your trusted source for investing success

Tag: life science companies

PharmaCyte Biotech Retains Facet Life Sciences to Guide Pancreatic Cancer Therapy Development Lifecycle with FDA

PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, officially announced today that PharmaCyte has retained Facet Life Sciences, Inc. (Facet) to guide PharmaCyte through its pancreatic cancer therapy development lifecycle with the U.S.

What Is Collaborative Care?

What Is Collaborative Care?

Precision medicine, medtech, “going beyond the pill”: these common phrases are signposts, marking the future path of medicine. Here’s another you should know: collaborative care.

GammaDelta Therapeutics Raises Seed Funding from Abingworth

Abingworth, the international investment group dedicated to life sciences, today announced that it has seeded GammaDelta Therapeutics Ltd, a new immunotherapy company. GammaDelta Therapeutics also received support from three organisations, Cancer Research Technology (CRT), King’s College London and the Francis Crick Institute. The company is being incubated at Abingworth’s London

Amylyx Announces $5 Million Series A Financing to Support Phase II Clinical Trial of AMX0035 for Treatment of Amyotrophic Lateral Sclerosis

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals Inc. announced today that it has completed a $5
million Series A financing to support its upcoming Phase II trial in
patients with Amyotrophic Lateral Sclerosis (ALS). Morningside Venture
led the financing and was joined by the ALS Investment Fund and former
Genzyme CEO Henri Termeer, as well as new

5 Top Life Science Stories for Q1 2015

Q1 is now over, and to mark the occasion, Life Science Investing News has assembled the articles that got the most traffic during the period. Unsurprisingly, readers were most interested in hearing about trends for 2015, though stock picks were also a key topic.

Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network